Sandra E. Poole
Direttore/Membro del Consiglio presso TRAVERE THERAPEUTICS, INC.
Patrimonio netto: 174 370 $ in data 31/05/2024
Posizioni attive di Sandra E. Poole
Società | Posizione | Inizio | Fine |
---|---|---|---|
TRAVERE THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 13/05/2019 | - |
Independent Dir/Board Member | 13/05/2019 | - | |
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | Direttore/Membro del Consiglio | 27/06/2019 | - |
Mythic Therapeutics, Inc.
Mythic Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mythic Therapeutics, Inc. engages in the development of cancer therapeutics. The company was founded on June 6, 2018 and is headquartered in Waltham, MA. | Direttore operativo | 01/07/2020 | - |
Storia della carriera di Sandra E. Poole
Precedenti posizioni note di Sandra E. Poole
Società | Posizione | Inizio | Fine |
---|---|---|---|
VALNEVA | Direttore/Membro del Consiglio | 30/06/2017 | 17/06/2020 |
Independent Dir/Board Member | 30/06/2017 | 17/06/2020 | |
CANDEL THERAPEUTICS, INC. | Direttore operativo | 10/01/2020 | 01/03/2020 |
LOGICBIO THERAPEUTICS, INC. | Direttore operativo | 01/04/2018 | 31/03/2019 |
S. Poole Consulting LLC
S. Poole Consulting LLC Miscellaneous Commercial ServicesCommercial Services S. Poole Consulting LLC provides business consulting services. The private company is based in Boston, MA. | Corporate Officer/Principal | 01/08/2016 | 01/03/2018 |
IMMUNOGEN, INC. | Direttore Tecnico/Scientifico/R&S | 17/09/2014 | 01/01/2017 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/02/1999 | 01/09/2014 |
Formazione di Sandra E. Poole
The University of Waterloo | Graduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 9 |
Canada | 2 |
Francia | 2 |
Posizioni
Chief Operating Officer | 3 |
Director/Board Member | 3 |
Independent Dir/Board Member | 2 |
Settori
Health Technology | 9 |
Consumer Services | 2 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 3 |
---|---|
CANDEL THERAPEUTICS, INC. | Health Technology |
VALNEVA | Health Technology |
TRAVERE THERAPEUTICS, INC. | Health Technology |
Aziende private | 6 |
---|---|
ImmunoGen, Inc.
ImmunoGen, Inc. BiotechnologyHealth Technology ImmunoGen, Inc. engages in the discovery and development of antibody-drug conjugates to improve outcomes for cancer patients. Its pipeline includes Mirvetuximab Soravtansine, IMGN632, IMGC936, and IMGN151. The company was founded on March 27, 1981 and is headquartered in Waltham, MA. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | Health Technology |
LogicBio Therapeutics, Inc.
LogicBio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LogicBio Therapeutics, Inc. engages in the development of a genome editing technology platform. It focuses on the commercialization of GeneRide, which enables the site-specific integration of a therapeutic transgene without nucleases or exogenous promoters by harnessing the native process of homologous recombination. Its pipeline includes LB-001, LB-301 and LB-401. The company was founded by Mark A. Kay, Leszek Lisowski, and Adi Barzel in August 2014 and is headquartered in Lexington, MA. | Health Technology |
S. Poole Consulting LLC
S. Poole Consulting LLC Miscellaneous Commercial ServicesCommercial Services S. Poole Consulting LLC provides business consulting services. The private company is based in Boston, MA. | Commercial Services |
Mythic Therapeutics, Inc.
Mythic Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mythic Therapeutics, Inc. engages in the development of cancer therapeutics. The company was founded on June 6, 2018 and is headquartered in Waltham, MA. | Health Technology |
- Borsa valori
- Insiders
- Sandra E. Poole
- Esperienza